CH681692A5 - - Google Patents

Download PDF

Info

Publication number
CH681692A5
CH681692A5 CH4034/90A CH403490A CH681692A5 CH 681692 A5 CH681692 A5 CH 681692A5 CH 4034/90 A CH4034/90 A CH 4034/90A CH 403490 A CH403490 A CH 403490A CH 681692 A5 CH681692 A5 CH 681692A5
Authority
CH
Switzerland
Prior art keywords
infusion
compounds
vascular
composition according
shock
Prior art date
Application number
CH4034/90A
Other languages
English (en)
French (fr)
Inventor
Pierre Braquet
De Lassauniere Pierre Chabrier
Jean-Michel Guillon
Michel Auguet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of CH681692A5 publication Critical patent/CH681692A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH4034/90A 1989-12-22 1990-12-19 CH681692A5 (enEXAMPLES)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898929076A GB8929076D0 (en) 1989-12-22 1989-12-22 Treatment of shock by blocking agents of edrf effect or formation

Publications (1)

Publication Number Publication Date
CH681692A5 true CH681692A5 (enEXAMPLES) 1993-05-14

Family

ID=10668428

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4034/90A CH681692A5 (enEXAMPLES) 1989-12-22 1990-12-19

Country Status (21)

Country Link
US (1) US5081148A (enEXAMPLES)
JP (1) JP2706578B2 (enEXAMPLES)
KR (1) KR950005866B1 (enEXAMPLES)
AT (1) AT403122B (enEXAMPLES)
AU (1) AU629777B2 (enEXAMPLES)
BE (1) BE1005531A5 (enEXAMPLES)
CA (1) CA2032904C (enEXAMPLES)
CH (1) CH681692A5 (enEXAMPLES)
DE (1) DE4041283C2 (enEXAMPLES)
DK (1) DK176168B1 (enEXAMPLES)
FR (1) FR2656220B1 (enEXAMPLES)
GB (2) GB8929076D0 (enEXAMPLES)
HK (1) HK134693A (enEXAMPLES)
IE (1) IE64403B1 (enEXAMPLES)
IT (1) IT1246511B (enEXAMPLES)
LU (1) LU87867A1 (enEXAMPLES)
MY (1) MY105328A (enEXAMPLES)
NL (1) NL194717C (enEXAMPLES)
OA (1) OA09337A (enEXAMPLES)
SE (1) SE504922C2 (enEXAMPLES)
ZA (1) ZA9010004B (enEXAMPLES)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468881B (sv) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
US5385940A (en) * 1992-11-05 1995-01-31 The General Hospital Corporation Treatment of stroke with nitric-oxide releasing compounds
US5585402A (en) * 1992-12-23 1996-12-17 Glaxo Wellcome Inc. Nitric oxide synthase inhibitors
US5436270A (en) * 1993-04-07 1995-07-25 National Science Council Method for protecting against endotoxin-induced shock
GB9312204D0 (en) * 1993-06-14 1993-07-28 Zeneca Ltd Therapeutic composition
GB9312761D0 (en) * 1993-06-21 1993-08-04 Wellcome Found Amino acid derivatives
US6297276B1 (en) 1993-10-04 2001-10-02 Glaxosmithkline Substituted urea and isothiourea derivatives as no synthase inhibitors
US6090846A (en) * 1994-06-01 2000-07-18 Glaxo Wellcome Inc. Substituted urea and isothiourea derivatives as no synthase inhibitors
US6225305B1 (en) 1993-10-04 2001-05-01 Glaxo Wellcome Inc. Substituted urea and isothiorea derivatives as no synthase inhibitors
ES2181726T3 (es) * 1993-10-21 2003-03-01 Searle & Co Amidinoderivados utiles como inhibidores de oxido nitrico sintasa.
ATE177078T1 (de) * 1993-10-21 1999-03-15 Searle & Co Amidino-derivate als no-synthetase inhibitoren
GB9404400D0 (en) * 1994-03-07 1994-04-20 Wood Pauline J Potentiation of bioreductive agents
DE69518631T2 (de) * 1994-03-10 2001-01-11 G.D. Searle & Co., Chicago L-n6-(1-iminoethyl)lysin - derivate und ihre verwendung als no-synthase - inhibitoren
US5684008A (en) * 1994-11-09 1997-11-04 G. D. Searle & Co. Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
FR2727111B1 (fr) * 1994-11-21 1997-01-17 Hoechst Lab Nouveaux analogues soufres d'aminoacides, leur procede de preparation et leurs applications comme medicaments
CA2206119C (en) * 1994-12-12 2008-05-13 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
FR2730930B1 (fr) 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
GB9504350D0 (en) * 1995-03-04 1995-04-26 Sod Conseils Rech Applic Arginine derivatives
CN1105706C (zh) * 1995-04-20 2003-04-16 G·D·瑟尔公司 用作氧化氮合成酶抑制剂的环状脒基制剂
US5830917A (en) * 1995-09-11 1998-11-03 G. D. Searle & Co. L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
BR9509985A (pt) * 1995-12-12 1998-11-03 Omeros Med Sys Inc Solução para irrigação e método para inibição de dor inflamação e esparmo
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
US6620848B2 (en) 1997-01-13 2003-09-16 Smithkline Beecham Corporation Nitric oxide synthase inhibitors
US6369272B1 (en) 1997-01-13 2002-04-09 Glaxosmithkline Nitric oxide synthase inhibitors
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
GB9811599D0 (en) 1998-05-30 1998-07-29 Glaxo Group Ltd Nitric oxide synthase inhibitors
JP2002517502A (ja) 1998-06-10 2002-06-18 ジー・ディー・サール・アンド・カンパニー 複素二環状及び三環状一酸化窒素シンターゼ阻害剤
US6344473B1 (en) 2000-08-07 2002-02-05 G.D. Searle & Co. Imidazoles useful as nitric oxide synthase inhibitors
WO2005063752A1 (en) 2003-12-30 2005-07-14 Vasopharm Biotech Gmbh 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB931921A (en) * 1960-12-22 1963-07-24 Lab Roques Therapeutic compositions intended for the treatment of any hepatic malfunctionings
DE1767212B1 (de) * 1967-04-13 1971-05-06 Sumitomo Chemical Co Verfahren zur Herstellung injizierbarer Arzneimittel
FR2115060A1 (en) * 1970-11-26 1972-07-07 Metabio Freeze-dried acetylsalicylates of lysine and arginine - easily prepd derivs of aspirin
CA1029660A (en) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention of gastric lesions
FR2320759A1 (fr) * 1975-08-11 1977-03-11 Union Pharma Scient Appl Solution d'acide acetylsalicylique extemporanee injectable
IT1127321B (it) * 1979-12-28 1986-05-21 Italfarmaco Spa Composizione farmaceutiche aventi specifiche proprieta' terapeutiche nei confronti dell'edema polmonare acuto,di alcuni stati di shock e dell'iperfibrinolisi
IT1127322B (it) * 1979-12-28 1986-05-21 Italfarmaco Spa Composizioni farmaceutiche con esaltazione dell'attivita' terapeutica di cortisonici
JPS5781409A (en) * 1980-11-10 1982-05-21 Toko Yakuhin Kogyo Kk External plaster
JPS57197211A (en) * 1981-05-28 1982-12-03 Sumitomo Chem Co Ltd Useful eye drop composition
JPS57200361A (en) * 1981-06-03 1982-12-08 Sumitomo Chem Co Ltd "indomethacin(r)" pharmaceutical with low irritant action
JPS6239524A (ja) * 1985-08-13 1987-02-20 Toko Yakuhin Kogyo Kk 消炎鎮痛軟膏剤
JPH0236570B2 (ja) * 1985-05-30 1990-08-17 Toko Yakuhin Kogyo Kk Shoenchintsunankozai
IT1201511B (it) * 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
DE3878812T2 (de) * 1987-02-20 1993-07-22 Shriners Hospitals For Cripple Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.

Also Published As

Publication number Publication date
BE1005531A5 (fr) 1993-09-28
JP2706578B2 (ja) 1998-01-28
DK304190D0 (da) 1990-12-21
IT9022413A1 (it) 1991-06-23
GB2240041B (en) 1993-09-01
IE904592A1 (en) 1991-07-03
KR910011253A (ko) 1991-08-07
DE4041283A1 (de) 1991-06-27
FR2656220B1 (fr) 1995-01-13
FR2656220A1 (fr) 1991-06-28
DE4041283C2 (de) 2000-07-13
ZA9010004B (en) 1991-10-30
LU87867A1 (fr) 1991-05-07
NL194717C (nl) 2003-01-07
KR950005866B1 (ko) 1995-06-02
AU6837690A (en) 1991-06-27
AT403122B (de) 1997-11-25
GB9028013D0 (en) 1991-02-13
CA2032904C (en) 1996-01-02
IT9022413A0 (it) 1990-12-18
GB2240041A (en) 1991-07-24
SE9003974D0 (sv) 1990-12-12
NL9002720A (nl) 1991-07-16
ATA260690A (de) 1997-04-15
AU629777B2 (en) 1992-10-08
MY105328A (en) 1994-09-30
SE504922C2 (sv) 1997-05-26
US5081148A (en) 1992-01-14
SE9003974L (sv) 1991-06-23
IE64403B1 (en) 1995-08-09
GB8929076D0 (en) 1990-02-28
HK134693A (en) 1993-12-17
CA2032904A1 (en) 1991-06-23
OA09337A (fr) 1992-09-15
DK304190A (da) 1991-06-23
NL194717B (nl) 2002-09-02
JPH04364124A (ja) 1992-12-16
DK176168B1 (da) 2006-11-13
IT1246511B (it) 1994-11-19

Similar Documents

Publication Publication Date Title
BE1005531A5 (fr) Agents bloquants de l'effet ou de la formation du facteur edrf pour le traitement des chocs.
EP0939654B1 (fr) Utilisation des inhibiteurs de no synthase et des piegeurs des formes reactives de l'oxygene pour le traitement de l'ischemie
FR2774591A1 (fr) Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
FR2914188A1 (fr) Nouvelle composition a base d'oxime de cholest-4-en-3-one
EP1464330B1 (fr) composition antiallergique comprenant des oligosaccharides et une saponine ou un acide aminé basique destinée à être administrée par voie topique ou par inhalation
ES2356986T3 (es) Agentes antitumorales.
BE895724A (fr) Nouvelle utilisation therapeutique de la dihydrocyclosporine d
LONGCOPE et al. The use of BAL (British anti-Lewisite) in the treatment of the injurious effects of arsenic, mercury and other metallic poisons
JP6377713B2 (ja) 薬剤
US5661188A (en) Therapeutic uses for sodium 2-mercaptoethanesulphonate (mesna)
JP5058799B2 (ja) グラプトペタルム属および近親植物の医薬的使用
CA2083825A1 (fr) Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation
EP3648768B1 (fr) Iméglimine pour la prévention et/ou le traitement du carcinome hépatocellulaire
FR2806911A1 (fr) Utilisation de mimetiques de la sod dans le traitement d'insuffisances hepatocellulaires
CH665637A5 (fr) 5-(3-n-butyloxalylaminophenyl)tetrazole comme agent antiasthmatique, composition le contenant et procede de preparation de la composition.
US20120207838A1 (en) Treatment of Psoriasis Using Oral Dosage Forms of Nitrone Spin Traps
JP2727431B2 (ja) 生体内ラジカル消去剤
CH678275A5 (enEXAMPLES)
FR2586352A1 (fr) Compositions pharmaceutiques contenant une coenzyme du type ubiquinone, douees d'activite de protection cardiaque et metabolique sur le metabolisme energetique musculaire
EP0150186A1 (fr) Composition a activite pharmaceutique amelioree et utilisation decelle-ci pour des usages veterinaires
RU2086238C1 (ru) N,n-дибензилглицин и его производные, обладающие способностью проникать через гематоэнцефалический барьер
JPH0621062B2 (ja) 肝障害抑制剤
JPH0283321A (ja) 膵臓疾患治療剤
FR2595248A1 (fr) Agent ameliorant pour la fibrose pulmonaire et son utilisation
JPH08208472A (ja) 抗肝炎剤

Legal Events

Date Code Title Description
PL Patent ceased